Thought Leadership
Unlocking the Power of AI and Machine Learning in Life Sciences
Life sciences companies are putting artificial intelligence (AI) and machine learning (ML) into practice, realizing its potential to revolutionize adverse event detection, diagnostics, and more. For AI and ML to be truly effective, you need to give context to your data, teaching...
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From...
Achieving Global Success in Clinical Trial Recruitment
TransPerfect's GlobalLink Connect integration with Adobe Experience Cloud enabled one of the world’s largest pharmaceutical companies to help visitors in 17 countries and 13 languages identify clinical trials that might be right for them or their loved ones....
Clinical Content Trends: 2023 Reflections and 2024 Projections
Over the past decade, the pharmaceutical industry has transformed significantly, giving way to breakthrough therapeutics and innovations for improved patient outcomes around the world. With these changes, there’s also been significant developments in the way organizations are...
LifeSci Talks COA Series | Licensing Challenges vs. eCOA Vendor Capabilities
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among...
COA White Paper | The Tale of Two Trials
In “The Tale of Two Trials,” Mark Wade takes an in-depth look at the benefits and drawbacks of the traditional, paper-based outcomes assessment method, as well as the advantages of the emerging electronic clinical outcomes assessment (eCOA) solutions. With each having the...
Data Standardization COA Whitepaper
With the surge of eCOA providers deploying differing technology platforms with differing architecture and file exchange processes, the landscape is shifting and becoming opaque. Deploying an eCOA solution faster and more costeffectively is a clearer focus for Sponsors now. Indeed...
LifeSci Talks COA Series | Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host of new challenges, including those surrounding technical interoperability, resistance to adopting new technologies, and the need for...
Buyer’s Guide: PV Reporting AI and Automation
Considerations for selecting modern pharmacovigilance (PV) and safety solutions that improve adverse event detection, assessment, understanding and prevention. Download your copy to gain expert insights into developing and implementing a robust automation strategy for PV &...
Keeping Patients at the Heart of Clinical Trials
Clinical trial patient recruitment continues to be challenging. Even with shifts to decentralize clinical trials and the addition of new vendors and technology, recruitment still is the primary cause of delays or discontinuation. What could we be missing? In this webinar, we...
The Imperative of Automation in Pharmacovigilance and Patient Safety
Uncover the transformative potential of tech-enabled pharmacovigilance (PV) processes to maximize patient safety and streamline reporting. This white paper outlines the practical application of Artificial Intelligence (AI), Translation Management Systems (TMS), and other...
LifeSci Talks COA Series | AI-Powered Innovations in Clinical Trials: Optimizing Every Step
Explore how artificial intelligence is rapidly changing the landscape of clinical trials, from discovering new therapies and complex calculations to protocol optimization. Discover how AI can generate study protocols, consent forms, and more, saving time and resources. Join us to...
Translation and Cultural Adaptation of Clinical Outcome Assessments (COAs): Is Machine Translation a Viable Option?
As technology continues to advance and the need to expedite drug development increases, the applications of Machine Translation (MT) and Artificial Intelligence (AI) in the translation process should be further explored. The capabilities of iterative learning and feedback can...
C3 Summit 2023 - Princeton
Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to...
C3 Summit 2023 - London
Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to...
C3 Summit 2023 - Boston
Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to...
C3 Summit 2023 - San Francisco
Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to...
LifeSci Talks COA Series | The Age of Bring Your Own Device: Considerations for Accessibility in Trial Design
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr. Florence Mowlem, VP of Science at ObvioHealth, to discuss maximizing patient accessibility in trial design. This includes implementing accommodations for patients...